A detailed history of Us Bancorp \De\ transactions in Zai Lab LTD stock. As of the latest transaction made, Us Bancorp \De\ holds 331 shares of ZLAB stock, worth $10,403. This represents 0.0% of its overall portfolio holdings.

Number of Shares
331
Previous 375 11.73%
Holding current value
$10,403
Previous $6,000 16.67%
% of portfolio
0.0%
Previous 0.0%

Shares

18 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 28, 2024

SELL
$16.25 - $24.14 $715 - $1,062
-44 Reduced 11.73%
331 $7,000
Q2 2024

Aug 06, 2024

BUY
$13.72 - $21.55 $5,145 - $8,081
375 New
375 $6,000
Q4 2023

Feb 09, 2024

BUY
$22.97 - $30.58 $4,157 - $5,534
181 Added 119.87%
332 $9,000
Q3 2023

Nov 03, 2023

SELL
$22.72 - $31.49 $3,158 - $4,377
-139 Reduced 47.93%
151 $3,000
Q2 2023

Aug 09, 2023

BUY
$25.3 - $39.67 $7,337 - $11,504
290 New
290 $8,000
Q3 2022

Oct 27, 2022

BUY
$34.2 - $51.69 $342 - $516
10 New
10 $0
Q2 2022

Aug 01, 2022

SELL
$23.14 - $49.68 $5,322 - $11,426
-230 Closed
0 $0
Q1 2022

May 11, 2022

SELL
$27.77 - $64.4 $89,697 - $208,012
-3,230 Reduced 93.35%
230 $10,000
Q4 2021

Feb 11, 2022

BUY
$54.9 - $105.21 $67,417 - $129,197
1,228 Added 55.02%
3,460 $217,000
Q3 2021

Nov 10, 2021

BUY
$105.0 - $178.37 $5,250 - $8,918
50 Added 2.29%
2,232 $235,000
Q2 2021

Aug 05, 2021

SELL
$125.11 - $180.0 $2,001 - $2,880
-16 Reduced 0.73%
2,182 $386,000
Q1 2021

Apr 28, 2021

BUY
$126.27 - $191.71 $20,329 - $30,865
161 Added 7.9%
2,198 $294,000
Q4 2020

Feb 04, 2021

BUY
$81.94 - $135.34 $26,466 - $43,714
323 Added 18.84%
2,037 $276,000
Q3 2020

Nov 10, 2020

BUY
$73.3 - $89.48 $66,336 - $80,979
905 Added 111.87%
1,714 $142,000
Q2 2020

Aug 07, 2020

BUY
$48.82 - $82.53 $21,383 - $36,148
438 Added 118.06%
809 $67,000
Q1 2020

May 13, 2020

BUY
$39.1 - $62.9 $5,904 - $9,497
151 Added 68.64%
371 $19,000
Q4 2019

Feb 04, 2020

BUY
$29.79 - $43.06 $2,442 - $3,530
82 Added 59.42%
220 $9,000
Q4 2018

Feb 13, 2019

BUY
$14.95 - $24.72 $2,063 - $3,411
138 New
138 $3,000

Others Institutions Holding ZLAB

About Zai Lab Ltd


  • Ticker ZLAB
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 97,908,704
  • Market Cap $3.08B
  • Description
  • Zai Lab Limited develops and commercializes therapies to treat oncology, autoimmune disorders, infectious diseases, and neuroscience primarily in Mainland China and Hong Kong. The company's commercial products include Zejula, a once-daily small-molecule poly polymerase 1/2 inhibitor; Optune, a device that delivers tumor treating fields; NUZYRA f...
More about ZLAB
Track This Portfolio

Track Us Bancorp \De\ Portfolio

Follow Us Bancorp \De\ and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Us Bancorp \De\, based on Form 13F filings with the SEC.

News

Stay updated on Us Bancorp \De\ with notifications on news.